GLP-1 medications, gut health
Gut Health on Ozempic: What GLP-1 Medications Do to Your Microbiome
Slower digestion, shifting bacteria, and how to support your gut while you adjust
Most people starting Ozempic, Wegovy or Mounjaro hear about the appetite effect. Fewer hear what happens to their gut. Here's what the research says, and what you can do about it.
The short version
- GLP-1 medications slow how fast your stomach empties. That's part of how they reduce appetite. Across 39 studies, nausea, vomiting, diarrhea and constipation were the most common side effects, and every GLP-1 medication raised the risk of nausea.1,2
- They also change which bacteria thrive in your gut. Akkermansia rose in several studies, though results were mixed.3
- Probiotics have been studied for nausea, bloating and constipation in people with digestive disorders, though not yet in GLP-1 users specifically.6,7
- A simple plan: a daily multi-strain probiotic, prebiotic fiber built up slowly, a targeted formula if symptoms persist, and your prescriber in the loop.*
- Supplements don't replace, copy or change how your medication works. They support the gut that's adjusting to it.
What GLP-1 medications actually do to your gut
GLP-1 receptor agonists (semaglutide, tirzepatide, liraglutide) were first developed for type 2 diabetes. The brand names you hear most often are Ozempic and Wegovy (semaglutide) and Mounjaro and Zepbound (tirzepatide). They work by mimicking a hormone your body makes called glucagon-like peptide-1, which signals your brain to reduce appetite and tells your stomach to slow down.
That "slow down" part is where gut health comes in. GLP-1 medications significantly delay gastric emptying, so food stays in your stomach and upper GI tract longer than it normally would.2 It's part of why you feel less hungry. It's also why so many people on these medications develop digestive symptoms they never had before.
Stomach
Delayed gastric emptying
Food lingers in the stomach longer, which reduces appetite but can cause bloating, fullness and nausea in many users.2
Microbiome
Bacteria shift
A 2025 review of 38 animal and human studies found GLP-1 drugs change gut bacteria composition, with Akkermansia rising in several of them.3
Colon
Reduced motility
Slower transit through the whole GI tract gives the colon more time to reabsorb water, which can lead to constipation and hard stools.
None of this is a reason to stop your medication. These effects are well documented, and for most people the benefits outweigh the discomfort. Knowing what's happening gives you a starting point for managing it.
The microbiome shift: what the research shows
Your gut microbiome holds trillions of bacteria that influence digestion, immune function and even mood. When you start a GLP-1 medication, two things change at once: how fast food moves through your system, and which bacteria live there.
A 2025 systematic review in Nutrients pulled together 38 animal and human studies and found that GLP-1 medications change gut microbiota composition. After dulaglutide, Bacteroides, Akkermansia and Ruminococcus rose. Semaglutide results were mixed: A. muciniphila rose, but overall diversity fell.3 In diet-induced obese mice, liraglutide and a dual GLP-1/GLP-2 drug produced smaller, discrete shifts in low-abundance gut species.4
The connection that matters
Short-chain fatty acids (SCFAs) like butyrate are made when gut bacteria ferment dietary fiber, and in an animal study (dogs), fermentable fiber increased the body's own GLP-1 secretion.5 Human results are less consistent: in one study, resistant starch didn't raise GLP-1 at all.14 Either way, that natural signal is short-lived and a different thing from your medication. Probiotics and fiber don't boost or stand in for the drug. What they can do is support the gut environment the drug is changing, so the two sit comfortably side by side.*
The practical takeaway: your medication is changing your gut environment, and supporting that environment with beneficial bacteria and fiber is a sensible companion to your treatment.*
Three GI side effects and what's behind them
In a 2025 network meta-analysis of 39 studies, nausea, vomiting, diarrhea and constipation were the most common GI effects, and every GLP-1 medication studied raised the risk of nausea.1 Many people also notice bloating and fullness as food sits longer. Here's what drives three of the most common complaints, and what the research says about each. One caveat up front: these probiotic studies were run in people with IBS, other digestive disorders or constipation, not in GLP-1 users.
Common complaint
Bloating and gas
Delayed stomach emptying means food sits longer and ferments. A 2023 meta-analysis of 82 trials in IBS found some probiotic combinations and Bacillus strains eased bloating and distension, though the certainty of that evidence was very low.9 A 2025 umbrella meta-analysis across GI disorders found probiotics lowered bloating risk by 26%.6
Common complaint
Constipation
Slower transit gives the colon more time to absorb water, leading to hard, infrequent stools. In adults with functional constipation, a meta-analysis found probiotics reduced whole-gut transit time by 13.75 hours and added nearly one bowel movement a week. The frequency gain held for multispecies probiotics but not for B. lactis or B. longum alone.7
Common complaint
Nausea
Food lingering in the stomach triggers nausea signals, especially during dose increases. Probiotic supplementation lowered nausea risk by 41% (RR 0.59) in people with GI disorders.6
These symptoms are usually strongest in the first weeks and around dose increases. They tend to ease over time, but for many people they hang on at a lower level. That's where targeted support comes in.
Strain evidence: what clinical research shows
Not all probiotics are interchangeable. For the digestive symptoms common during GLP-1 therapy, the strains that have actually been studied matter more than the raw CFU count. Here's what the clinical evidence says.
| Strain | What the study found | Why it's relevant on a GLP-1 |
|---|---|---|
| B. lactis HN019 | Shortened whole-gut transit time in a dose-dependent way and reduced 8 of 9 functional GI symptoms10 | Transit is exactly what slows down on these medications |
| L. acidophilus NCFM + B. lactis Bi-07 | Improved bloating vs placebo at four weeks11 | Bloating and fullness are common as food sits longer |
| B. lactis HN019 (8 weeks) | Not better than placebo for functional constipation; fecal SCFAs and microbiota showed no differences12 | A reminder that single-strain results don't always repeat |
| B. lactis (multiple studies) | Improved stool frequency in chronic constipation; probiotic mixtures did not reach significance8 | Supports B. lactis, though it conflicts with the other constipation meta-analysis on mixtures |
The two constipation meta-analyses disagree: one found the stool-frequency gain for multispecies probiotics but not B. lactis alone,7 the other found it for B. lactis but not for mixtures.8 All of these trials tested specific strains at set doses in people who weren't on GLP-1 medications. Our formulas weren't the products studied, so read them as research on the strains, not on any product.
Bifidobacterium lactis HN019 shows up twice, with different results. It shortened transit time in a 2011 dose-response trial,10 but a newer 8-week trial in functional constipation found no benefit over placebo.12 Transit is what GLP-1 therapy slows, so it's a strain worth watching rather than a settled answer. The Intense Care Gas & Bloating formula includes this strain as a clinically researched component.
Building a GLP-1 gut support protocol
Based on the research above, a practical approach rests on three pillars: a multi-strain probiotic, prebiotic fiber and timing. Here's a week-by-week framework.
-
1
Weeks 1-2: start with a daily probiotic
Begin with a multi-strain probiotic to support microbiome diversity while your body adjusts to the medication. If nausea is a concern, take it at a different time than your injection. A formula with 60 diverse strains and 60 billion CFU gives broad-spectrum support.*
-
2
Weeks 2-4: add fiber to feed the good bacteria
Introduce a prebiotic fiber supplement at half the recommended serving. Your gut bacteria ferment fiber into short-chain fatty acids, and in an animal study (dogs), fermentable fiber increased GLP-1 secretion.5 Build up to a full serving over 1-2 weeks to keep bloating down while you adjust.*
-
3
Weeks 4-8: target what's still bothering you
If occasional bloating or gas continues after the adjustment period, consider a formula with strains studied for those exact symptoms, like B. lactis HN019, which has been studied for transit time. It works alongside your foundation probiotic.*
-
4
Month 2 and beyond: keep it consistent
Continue your daily probiotic and fiber as ongoing maintenance. In a small study of 20 healthy Japanese volunteers, a supplement combining glutamine, fiber and oligosaccharides raised GLP-1 and GLP-2 more than glucose did.15 Fiber alone is less clear: in 30 healthy men, resistant starch lowered GLP-1 after breakfast.14 Any effect here is your natural gut signaling, which is separate from how your medication works.*
Talk to your provider
Always discuss supplement changes with your prescribing doctor or pharmacist, especially while on GLP-1 therapy. Probiotics and fiber are generally well tolerated, but your provider knows your full medication and health picture. Severe or persistent vomiting, abdominal pain or constipation needs a call to your prescriber, not a supplement.
Explore the gut support range
Vital Flora Ultra Daily
60B CFU, 60 strains, 7 prebiotics
The flagship daily probiotic, formulated by Brenda Watson, CNC. Broad-spectrum microbiome support with 7 organic prebiotics.*
HN019
Intense Care Gas & Bloating
65B CFU, 65 strains, 4-Biotics
Targeted 4-in-1 formula with clinically researched B. lactis HN019 for occasional gas, bloating and abdominal discomfort.*
Vital Fiber
13 g fiber, USDA Organic, psyllium free
USDA Organic triple-source prebiotic fiber. Feeds beneficial gut bacteria and supports SCFA production.*
Not sure where to start? The quiz below routes you in three questions. New to fiber? Our gentle fiber guide shows how to build up without extra bloating.
Which gut support fits your GLP-1 journey?
Find your next step in three questions
Based on the research in this article. Not a diagnosis, and not a substitute for your prescriber's advice.
What's your main digestive concern since starting your GLP-1 medication?
How long have you been on your GLP-1 medication?
Do you take a probiotic or fiber supplement now?
Your next step
Build the foundation first
Bloating is common in the first weeks while your body adjusts, and it often eases. Start with a daily multi-strain probiotic, then add prebiotic fiber at half a serving and build up slowly.* If occasional bloating is still there after the adjustment period, a targeted formula is the next step.
Your next step
Targeted bloating support
Bloating that's outlasted the first month is worth targeting. B. lactis HN019 reduced 8 of 9 functional GI symptoms in a dose-dependent way, and a two-strain combination improved bloating vs placebo at four weeks. Those trials weren't in GLP-1 users, but they're the strongest leads we have.
A targeted formula for occasional gas and bloating, paired with prebiotic fiber to feed your beneficial bacteria, lines up with that evidence.*
Your next step
Constipation and regularity support
GLP-1 medications slow gut transit, and constipation is where you feel it. In a meta-analysis, probiotics shortened whole-gut transit by 13.75 hours and added nearly one bowel movement a week in adults with functional constipation. Pairing a high-diversity probiotic with prebiotic fiber supports both motility and stool bulk.* If you already take a probiotic, fiber is the piece to add.
Your next step
Fiber's in place, so check the rest
Slower transit gives your colon more time to pull water out of stool, so fiber works best with plenty of fluid. If you don't take a daily probiotic yet, that's the lever to add: probiotics shortened transit time in constipated adults.*
If constipation is persistent or severe, tell your prescriber. It's a known side effect and they'll want to hear about it.
Your next step
Give your body time to adjust
Nausea is usually worst in the first weeks and tends to ease within 4-8 weeks. A broad-spectrum daily probiotic supports microbiome diversity during this transition, and you can take it whenever it sits best, such as in the evening.* Hold off on adding fiber until your stomach settles.
Your next step
Lingering nausea is worth a call
Nausea that's still around after three months, outside of dose increases, is worth raising with your prescriber. They may want to adjust your plan.
Alongside that, a daily probiotic supports overall digestive comfort. In people with GI disorders, probiotics lowered nausea risk by 41%.*
Your next step
Foundation microbiome support
Getting ahead of symptoms makes sense. GLP-1 medications shift gut bacteria composition, and a broad-spectrum probiotic with 60 diverse strains helps maintain the diversity your microbiome needs during this transition.*
Your next step
Add the fuel: prebiotic fiber
Your probiotic is in place, so fiber is the missing pillar. Gut bacteria ferment fiber into short-chain fatty acids, and fiber also supports regularity when transit slows.* Start at half a serving and build up over 1-2 weeks.
Your next step
Stay consistent
You already have the foundation and the fuel. Keep both daily, since steady use is what the research rewards. If occasional gas or bloating shows up around a dose increase, a targeted formula can step in.*
Your next step
Comprehensive gut support
Nausea while you're still adjusting often comes with other digestive changes. The research supports a layered approach: a broad-spectrum daily probiotic for microbiome diversity, prebiotic fiber for SCFA production and regularity, and a targeted formula for your most persistent symptom.* If nausea is severe, call your prescriber.
Frequently asked questions
Yes, for most people. Probiotics are dietary supplements, not medications, and no drug interactions have been reported between probiotics and GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound). Still, mention any new supplement to your prescribing doctor or pharmacist so they have your full health picture.
The evidence is encouraging, though it comes from people with digestive disorders rather than GLP-1 users. A 2025 meta-analysis found probiotic supplementation lowered bloating risk by 26%, and a combination of L. acidophilus NCFM and B. lactis Bi-07 improved bloating compared with placebo at four weeks.6,11 Bloating on a GLP-1 is linked largely to delayed gastric emptying, and B. lactis HN019 has been shown to improve gut transit time in a dose-dependent way.10 Results vary, and it may take 2-4 weeks of consistent use to notice a difference in occasional bloating.*
Take your probiotic at the same time every day, whatever your injection day. Consistency matters more than timing relative to your GLP-1 dose. If nausea is worst on injection day or the day after, some people take their probiotic in the evening on those days or with a little food. The key is daily use, since the benefits in research come from sustained supplementation, not single doses.*
"Damage" isn't the right word, but GLP-1 medications do change microbiome composition. A 2025 systematic review of 38 animal and human studies found GLP-1 medications do shift gut bacteria. Bacteroides, Akkermansia and Ruminococcus rose after dulaglutide; with semaglutide, Akkermansia rose but overall diversity fell.3 Think of it as reorganization rather than destruction. The concern is that reduced microbial diversity can affect digestion and immune function over time, which is why supporting your microbiome with a diverse multi-strain probiotic during GLP-1 therapy makes practical sense.*
For many people, yes. Fiber supports regularity when transit slows, and feeds the gut bacteria that make short-chain fatty acids. Whether it raises your own GLP-1 is less clear in people: a glutamine, fiber and oligosaccharide supplement raised it in 20 volunteers,15 while resistant starch lowered it after breakfast in 30 healthy men.14 The animal research is more consistent.5 Start with half the recommended serving and increase over 1-2 weeks, since adding fiber too quickly when gut motility is already slow can temporarily increase bloating. An insoluble-dominant fiber (like pea, flax and hemp) tends to produce less gas than psyllium-based formulas.*
For most people, the worst GI symptoms (especially nausea) improve within the first 4-8 weeks as the body adjusts. Symptoms often flare again during dose increases, and some people have low-level bloating or constipation throughout treatment. In a 2025 analysis of 39 studies, every GLP-1 medication raised the risk of nausea, and constipation and diarrhea were also common.1 Proactive gut support with probiotics and fiber may help make these adjustment periods more comfortable.*
Not all probiotics are equal here. The research points to two things that matter most: strain diversity, and specific strains studied for digestive comfort. Probiotics can shift the makeup of the gut microbiota, but the effects depend on the strain.13 Even the meta-analyses disagree on whether mixtures or single strains do better for constipation.7,8 For transit time, B. lactis HN019 has some of the best evidence, reducing 8 of 9 functional GI symptoms in a 2011 trial,10 though a later 8-week trial found no benefit over placebo.12 Look for a formula that offers both diversity (many strains) and researched strains for your main symptom.*
References
- Ismaiel A, et al. Gastrointestinal adverse events associated with GLP-1 RA in non-diabetic patients with overweight or obesity: a systematic review and network meta-analysis. Int J Obes (Lond). 2025;49(10):1946-1957. PubMed
- Maselli DB, Camilleri M. Effects of GLP-1 and Its Analogs on Gastric Physiology in Diabetes Mellitus and Obesity. Adv Exp Med Biol. 2021;1307:171-192. PubMed
- Gofron KK, et al. Effects of GLP-1 Analogues and Agonists on the Gut Microbiota: A Systematic Review. Nutrients. 2025;17(8). PubMed
- Madsen MSA, et al. Metabolic and gut microbiome changes following GLP-1 or dual GLP-1/GLP-2 receptor agonist treatment in diet-induced obese mice. Sci Rep. 2019;9(1):15582. PubMed
- Massimino SP, et al. Fermentable dietary fiber increases GLP-1 secretion and improves glucose homeostasis despite increased intestinal glucose transport capacity in healthy dogs. J Nutr. 1998;128(10):1786-93. PubMed
- Zeng Q, et al. Probiotics and gastrointestinal disorders: an umbrella meta-analysis of therapeutic efficacy. Eur J Med Res. 2025;30(1):515. PubMed
- Zhang C, et al. Meta-analysis of randomized controlled trials of the effects of probiotics on functional constipation in adults. Clin Nutr. 2020;39(10):2960-2969. PubMed
- van der Schoot A, et al. Probiotics and synbiotics in chronic constipation in adults: A systematic review and meta-analysis of randomized controlled trials. Clin Nutr. 2022;41(12):2759-2777. PubMed
- Goodoory VC, et al. Efficacy of Probiotics in Irritable Bowel Syndrome: Systematic Review and Meta-analysis. Gastroenterology. 2023;165(5):1206-1218. PubMed
- Waller PA, et al. Dose-response effect of Bifidobacterium lactis HN019 on whole gut transit time and functional gastrointestinal symptoms in adults. Scand J Gastroenterol. 2011;46(9):1057-64. PubMed
- Ringel-Kulka T, et al. Probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 versus placebo for the symptoms of bloating in patients with functional bowel disorders: a double-blind study. J Clin Gastroenterol. 2011;45(6):518-25. PubMed
- Ala-Jaakkola R, et al. Effect of an 8-Week Bifidobacterium lactis HN019 Supplementation on Functional Constipation: A Multi-Center, Triple-Blind, Randomized, Placebo-Controlled Trial. Mol Nutr Food Res. 2025;69(17):e70081. PubMed
- Chandrasekaran P, et al. Effects of Probiotics on Gut Microbiota: An Overview. Int J Mol Sci. 2024;25(11). PubMed
- Bodinham CL, et al. Endogenous plasma glucagon-like peptide-1 following acute dietary fibre consumption. Br J Nutr. 2013;110(8):1429-33. PubMed
- Joo E, et al. Enteral supplementation with glutamine, fiber, and oligosaccharide modulates incretin and glucagon-like peptide-2 secretion. J Diabetes Investig. 2015;6(3):302-8. PubMed